2,6-diaminopurine 2',3'-dideoxyriboside has been researched along with dideoxyadenosine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, BD; Broder, S; Huryn, DM; Mitsuya, H; Sim, I; Sluboski, BC; Tam, SY; Weigele, M | 1 |
| Balzarini, J; Dalley, NK; De Clercq, E; Herdewijn, P; Robins, MJ; Wood, SG | 1 |
| Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC | 1 |
| Balzarini, J; De Clercq, E; Naesens, L; Robins, MJ | 1 |
| Balzarini, J; De Clercq, E | 1 |
| Baba, M; Balzarini, J; de Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Wood, SG | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Desmyter, J; Herdewijn, P; Madej, D; Pauwels, R; Robins, MJ; Zou, RM | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Zou, RM | 1 |
| Balzarini, J; De Clercq, E; Herdewijn, P; Robins, MJ; Zou, RM | 1 |
| Kitos, TE; Tyrrell, DL | 1 |
| Howe, AY; Robins, MJ; Tyrrell, DL; Wilson, JS | 1 |
11 other study(ies) available for 2,6-diaminopurine 2',3'-dideoxyriboside and dideoxyadenosine
| Article | Year |
|---|---|
Synthesis and anti-HIV activity of isonucleosides.
Topics: Antiviral Agents; Cells, Cultured; Chromatography, Liquid; Dideoxynucleosides; Drug Stability; Gene Products, gag; HIV-1; Humans; Isomerism; Monocytes; Spectrum Analysis; Virus Replication | 1992 |
Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides.
Topics: Animals; Antiviral Agents; Cell Transformation, Viral; Chemical Phenomena; Chemistry; Dideoxyadenosine; Dideoxynucleosides; Mice; Microbial Sensitivity Tests; Models, Molecular; Retroviridae; Solubility; X-Ray Diffraction | 1989 |
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine | 2007 |
Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
Topics: Animals; Antiviral Agents; Cell Line; Cell Transformation, Viral; Cytopathogenic Effect, Viral; Didanosine; Dideoxyadenosine; Drug Synergism; Fibroblasts; HIV; Humans; Mice; Mice, Inbred Strains; Moloney murine sarcoma virus; Ribavirin; Sarcoma, Experimental; Virus Replication | 1990 |
The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
Topics: Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Synergism; Simplexvirus; Vaccinia virus; Vidarabine; Viral Plaque Assay | 1989 |
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
Topics: Adenosine Deaminase; Antimetabolites; Antiviral Agents; Coformycin; Deoxyadenosines; Deoxyguanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Pentostatin; Prodrugs; Solubility; Virus Replication | 1988 |
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
Topics: Adenosine Deaminase; Animals; Antiviral Agents; Cell Line; Deamination; Deoxyadenosines; Dideoxyadenosine; HIV; Humans; Mice; Moloney murine sarcoma virus; Structure-Activity Relationship; Tumor Cells, Cultured | 1988 |
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Topics: Adenosine Deaminase Inhibitors; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cell Transformation, Viral; Deoxyadenosines; Dideoxyadenosine; DNA Replication; HIV; HIV Antigens; Humans; Virus Replication | 1987 |
The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
Topics: Adenosine Deaminase; Animals; Cattle; Deoxyadenosines; Dideoxyadenosine; Dideoxynucleosides; DNA Replication; HIV; Intestines; Kinetics; Nucleoside Deaminases; Substrate Specificity; Virus Replication | 1987 |
Intracellular metabolism of 2',3'-dideoxynucleosides in duck hepatocyte primary cultures.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cells, Cultured; Deoxycytidine; Dideoxyadenosine; Dideoxynucleosides; Ducks; Hepatitis B Virus, Duck; Liver; Phosphorylation; Zalcitabine | 1995 |
Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2',3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.
Topics: Animals; Antiviral Agents; Blotting, Northern; Blotting, Southern; Deoxyguanine Nucleotides; Depression, Chemical; Dideoxyadenosine; Dideoxynucleotides; DNA-Directed DNA Polymerase; Ducks; Hepatitis B Virus, Duck; RNA-Directed DNA Polymerase; Transcription, Genetic; Virus Replication; Zalcitabine | 1996 |